LINC01568

Across TCGA pan-cancer cohorts, LINC01568 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated LINC01568 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher LINC01568 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC01568 expression acts as an unfavorable survival marker.

BLCA, CHOL, and LIHC are the cancer types where LINC01568 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	All	0.138	0.371	.001	75	view →
CHOL	DFS	Tertile	II,III,IV	0.016	0.406	<.001	72	view →
LIHC	OS	Tertile	II,III,IV	0.264	0.789	<.001	27	view →
BRCA	OS	Tertile	III,IV	0.265	0.578	.027	24	view →
ACC	OS	Quartile	IV	0.251	0.774	<.001	18	view →
STAD	DFS	Median	IV	0.152	0.503	.006	17	view →
THCA	OS	Tertile	IV	0.720	1.000	.004	12	view →
DLBC	OS	Tertile	III,IV	0.272	1.000	.038	9	view →
SKCM	OS	Tertile	All	0.684	0.800	.015	9	view →
MESO	DFS	Tertile	IV	0.176	0.448	.012	6	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

LINC01568–BLCA (DFS)

Open the BLCA breakdown →